Related Experiment Video

Updated: Jun 8, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice

Stefan Lundeberg1, James A Roelofse

  • 1Department of Pediatric Anesthesia and Intensive Care, Pain Treatment Service, Astrid Lindgren Children's Hospital, Stockholm, Sweden. stefan.lundeberg@karolinska.se

Paediatric Anaesthesia
|September 21, 2010
PubMed

Insights

Sufentanil provides stable hemodynamics in pediatric patients. However, its pharmacokinetics, particularly clearance maturation and the impact of age on drug activity, require further investigation in children.

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Pediatric Critical Care

Background:

  • Sufentanil is a potent synthetic opioid used in pediatric anesthesia.
  • It establishes a stable hemodynamic profile, especially in compromised pediatric patients.
  • Opioid pharmacokinetics, including clearance and active fraction, vary significantly with age in children.

Purpose of the Study:

  • To review the pharmacokinetics and pharmacodynamics of sufentanil in pediatric populations.
  • To highlight the influence of age-related physiological changes on sufentanil metabolism and distribution.
  • To discuss the potential of intranasal sufentanil for pediatric procedural care.

Main Methods:

  • Literature review of studies on sufentanil pharmacokinetics and pharmacodynamics in children.
  • Analysis of age-dependent factors affecting drug clearance and protein binding.
  • Evaluation of intranasal sufentanil administration data.

Main Results:

  • Sufentanil clearance per kilogram is higher in children than adults.
  • The primary metabolic pathway involves the P450 CYP3A4 enzyme, with reduced activity in neonates.
  • Age impacts the free active fraction due to variations in alpha-1-acid glycoprotein levels.

Conclusions:

  • Intranasal sufentanil is a safe and effective option for pediatric premedication, sedation, and analgesia.
  • Further research is needed on the pharmacokinetics and pharmacodynamics of sufentanil infusions in children.
  • Understanding age-related pharmacokinetic maturation is crucial for optimizing pediatric sufentanil use.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...